Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.0250
0.00 (0.00%)
May 25, 2026, 9:30 AM EST
Sofgen Pharma Market Cap
Sofgen Pharma has a market cap or net worth of $58.12 million as of May 26, 2026. Its market cap has decreased by -80.71% in one year.
Market Cap
58.12M
Enterprise Value
333.63M
Revenue
373.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since December 9, 2019, Sofgen Pharma's market cap has decreased from 239.85M to 58.12M, a decrease of -75.77%. That is a compound annual growth rate of -19.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 58.12M | 0.51% |
| Dec 31, 2025 | 57.83M | -78.10% |
| Dec 31, 2024 | 264.01M | -42.51% |
| Dec 29, 2023 | 459.19M | -22.48% |
| Dec 30, 2022 | 592.33M | -46.15% |
| Dec 31, 2021 | 1.10B | 323.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 372.12M |
| Jushi Holdings | 89.86M |
| Earth Science Tech | 48.07M |
| Growth Stalk Holdings | 46.05M |
| Radnostix | 38.68M |
| MariMed | 29.94M |
| High Sierra Technologies | 28.98M |
| Raphael Pharmaceutical | 28.25M |